What is MLH Clinician?
Notice
Links marked with an asterisk (*) require MLH network access or Phone Factor authentication.
To contact MLH Clinician, email MLHClinician@mlhs.org.
Advisories
News From
- Infectious Diseases
- Pathology
- Radiology
- Oncology
- OB/GYN
- Pediatrics
- Orthopaedics
- Quality and Safety
- Emergency Medicine
- Mirmont
- Surgery
- Laboratories
- Cardiology
- Dept of Medicine
- Nephrology
- Gastroenterology
- Pharmacy
- Main Line HealthCare
- Clinical Informatics
- Family Practice
- Pulmonary
- Anesthesiology
- Palliative
- Administrative
- Outpatient Centers
- Geriatrics
- Hospitalist
Department News
- Infectious Diseases
- Pathology
- Radiology
- Oncology
- OB/GYN
- Pediatrics
- Orthopaedics
- Quality and Safety
- Emergency Medicine
- Mirmont
- Surgery
- Laboratories
- Cardiology
- Dept of Medicine
- Nephrology
- Gastroenterology
- Pharmacy
- Main Line HealthCare
- Clinical Informatics
- Family Practice
- Pulmonary
- Anesthesiology
- Palliative
- Administrative
- Outpatient Centers
- Geriatrics
- Hospitalist
Resources
Category Archives: Clinician News
Best read of the week
Hospitals can preview CMS star ratings through December Becker’s Hospital Review: CMS is making its preview of the February 2019 Hospital Compare star ratings and quality data available on QualityNet from Dec. 1 to Dec. 30. Additional news media … Continue reading
Heartfelt holiday wishes from MLH and holiday meal schedule
By Barbara Wadsworth, SVP, chief nursing officer, and Paul Yakulis, SVP, Human Resources With the festive season upon us, on behalf of MLH leadership, we’d like to pause to say thank you for all that you have helped us accomplish … Continue reading
Infection Prevention planning for The Joint Commission (TJC)
By Mark Ingerman, MD & Eileen Sherman TJC is planning visits to all five facilities of the Main Line Health System (MLHS) in the near future. These visits are unannounced surveys. There are several TJC standards from an Infection Prevention … Continue reading
Main Line HealthCare updates
Main Line HealthCare Welcomes: NEW – MLHC Pain Management at Lankenau Soorena Khojasteh, MD Victor I. Adamov, MD (inpt consult coverage only) Lankenau Medical Center, MOB East, Suite 261 100 E. Lancaster Avenue, Wynnewood, PA 19096 610.658.1928 / www.mainlinehealth.org/mlhcpain … Continue reading
In memoriam: Frank J. Manfrey, DO
We regret to inform you that Frank Manfrey, DO, passed away in November. He was on staff at Bryn Mawr and Paoli Hospitals and served as chair of the Department of Obstetrics and Gynecology. In lieu of flowers, the family … Continue reading
Mirmont Treatment Center designated an Aetna Institute of Quality®
Mirmont Treatment Center has been designated an Aetna Institute of Quality® for Behavioral Health—Substance Abuse. Aetna makes information about the quality and cost of health care services available to its members to help them make informed decisions about their health … Continue reading
Main Line Health Named to CHIME HealthCare’s 2018 Most Wired
For the 10th consecutive year, Main Line Health (MLH) was named to CHIME HealthCare’s Most Wired list for 2018. Most Wired is celebrating its 20th year as the industry’s benchmark of quality in health care IT, and its first year … Continue reading
Diversity & Inclusion holiday observances
Click here for the holidays celebrated in the month of December. A monthly calendar of Diversity & Inclusion events can be viewed on the Diversity & Inclusion intranet page.
STEEEP Huddle: E for Equitable
This week’s STEEEP Huddle topic – submitted by Michael Miller, manager, Workers’ Compensation and Employee Safety, focuses on Temporary Alternative Duty (TAD), a MLH policy that provides modified work to employees while they recover from their on-the-job injury. Last year, 177 … Continue reading
Clinical Trial of the Week: Treatment trial for men with localized intermediate-risk prostate cancer
By Donna Loyle, communications specialist, LIMR Main Line Health researchers are conducting a treatment trial for men diagnosed with stage IIA-B prostate cancer. Study #NRG GU005 is a phase III clinical trial that seeks to determine the safety and efficacy … Continue reading